ATP13A2 Antibody - BSA Free
Novus Biologicals | Catalog # NB110-41486
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Format
Product Specifications
Immunogen
Localization
Clonality
Host
Isotype
Scientific Data Images for ATP13A2 Antibody - BSA Free
Western Blot: ATP13A2 Antibody [NB110-41486]
Western Blot: ATP13A2 Antibody [NB110-41486] - Detection of ATP13A2 in mouse brain membrane lysate.Immunohistochemistry: ATP13A2 Antibody [NB110-41486]
Immunohistochemistry: ATP13A2 Antibody [NB110-41486] - Staining of neurons and neuropils using a concentration of 10ug/ml. Human brain, 40X.Simple Western: ATP13A2 Antibody [NB110-41486]
Simple Western: ATP13A2 Antibody [NB110-41486] - Simple Western lane view shows a specific band for ATP13A2 in 0.5 mg/ml of Human Brain lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.Western Blot: ATP13A2 Antibody - BSA Free [NB110-41486] -
Effects of Zn2+ on ATP13A2, alpha -synuclein, and autophagy–lysosome pathway in HEK293 alpha -synuclein-DsRed cells. (a) Cell viability of HEK293 alpha -synuclein-DsRed cells incubated with different concentrations of Zn2+ for 12 and 24 h. All values are presented as the mean +/- standard error of the mean (SEM) of at least three independent experiments. (b) TSQ staining was used to verify the zinc fluorescence intensity in HEK293 alpha -synuclein-DsRed cells with a medium containing 10 or 75 μM ZnSO4. Bar = 25 μm. (c) HEK293 alpha -synuclein-DsRed cells were untreated or treated with 75 μM ZnSO4 for 12 h. Cells were observed using confocal microscopy after staining with ATP13A2 and DAPI. The spontaneous red fluorescence of HEK293 alpha -synuclein-DsRed cells represented the expression levels of alpha -synuclein. Scale bar = 25 μm. (d–m) HEK293 alpha -synuclein-DsRed cells were treated with 10 or 75 μM ZnSO4 for 12 h. Immunoblot images ((d,f), left panels) and quantification ((e,g,h), right panels) show the expression of ATP13A2 (d), p-alpha -synuclein and alpha -synuclein (f) in the HEK293 alpha -synuclein-DsRed cells. Autophagy–lysosome pathway ((i), representative pictures; (j–m) quantification): the expression levels of LAMP-1 (i,j), LAMP-2a (i,k), P62 (i,l), LC3 I and LC3 II ((i,m), quantification of ratio of LC3II to LC3I) were determined using Western blot analysis with beta -actin as an internal control. All data from at least three independent experiments are represented as the means +/- SEM. * p < 0.05, ** p < 0.01 with respect to the control group. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35887392), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Western Blot: ATP13A2 Antibody - BSA Free [NB110-41486] -
Zn2+ treatment reduces spatial exploration behavior and increases the expression levels of ATP13A2 protein in the brains of mice. The nine-month-old alpha -synuclein-GFP mouse models were treated with different doses of ZnSO4 (20 or 200 ppm) for three months. (a) Total distance traveled in open field exploration in 5 min. (b) Movement distance in zone center showing 5 min of open field exploration by the mice. (c) Time spent in the center zone showing 5 min of open field exploration by the mice. (d) Five minutes movement tracks of open field exploration by the mice. ((a–d), n = 10 mice per group) (e) Zinc levels in the brain tissue were determined using ICP-MS ((e), n = 6 mice per group), and expression of the ATP13A2 (g), representative pictures; (f), quantification; n = 6 mice per group) was analyzed using immunoblotting. (h) ATP13A2 positive reaction was detected in substantia nigra pars compacta cells via immunohistochemistry using ATP13A2 antibody (scale bar = 50 μm) ((h), n = 6 mice per group). Data are represented as the means +/- SEM. The maximum and minimum values were removed from each group. Compared with the control group * p < 0.05, ** p < 0.01. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35887392), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Immunocytochemistry/ Immunofluorescence: ATP13A2 Antibody - BSA Free [NB110-41486] -
Effects of Zn2+ on ATP13A2, alpha -synuclein, and autophagy–lysosome pathway in HEK293 alpha -synuclein-DsRed cells. (a) Cell viability of HEK293 alpha -synuclein-DsRed cells incubated with different concentrations of Zn2+ for 12 and 24 h. All values are presented as the mean +/- standard error of the mean (SEM) of at least three independent experiments. (b) TSQ staining was used to verify the zinc fluorescence intensity in HEK293 alpha -synuclein-DsRed cells with a medium containing 10 or 75 μM ZnSO4. Bar = 25 μm. (c) HEK293 alpha -synuclein-DsRed cells were untreated or treated with 75 μM ZnSO4 for 12 h. Cells were observed using confocal microscopy after staining with ATP13A2 and DAPI. The spontaneous red fluorescence of HEK293 alpha -synuclein-DsRed cells represented the expression levels of alpha -synuclein. Scale bar = 25 μm. (d–m) HEK293 alpha -synuclein-DsRed cells were treated with 10 or 75 μM ZnSO4 for 12 h. Immunoblot images ((d,f), left panels) and quantification ((e,g,h), right panels) show the expression of ATP13A2 (d), p-alpha -synuclein and alpha -synuclein (f) in the HEK293 alpha -synuclein-DsRed cells. Autophagy–lysosome pathway ((i), representative pictures; (j–m) quantification): the expression levels of LAMP-1 (i,j), LAMP-2a (i,k), P62 (i,l), LC3 I and LC3 II ((i,m), quantification of ratio of LC3II to LC3I) were determined using Western blot analysis with beta -actin as an internal control. All data from at least three independent experiments are represented as the means +/- SEM. * p < 0.05, ** p < 0.01 with respect to the control group. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35887392), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Applications for ATP13A2 Antibody - BSA Free
Immunohistochemistry
Simple Western
Western Blot
In Simple Western only 10 - 15 uL of the recommended dilution is used per data point.
See Simple Western Antibody Database for Simple Western validation: Tested in Human Brain lysate 0.5 mg/mL, separated by Size, antibody dilution of 1:100. Separated by Size-Wes, Sally Sue/Peggy Sue.
Formulation, Preparation, and Storage
Purification
Formulation
Format
Preservative
Concentration
Shipping
Stability & Storage
Background: ATP13A2
Alternate Names
Gene Symbol
Additional ATP13A2 Products
Product Documents for ATP13A2 Antibody - BSA Free
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for ATP13A2 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Citations for ATP13A2 Antibody - BSA Free
Customer Reviews for ATP13A2 Antibody - BSA Free
There are currently no reviews for this product. Be the first to review ATP13A2 Antibody - BSA Free and earn rewards!
Have you used ATP13A2 Antibody - BSA Free?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for ATP13A2 Antibody - BSA Free (NB110-41486):
Western Blot Protocol
1. Perform SDS-PAGE (4-12%) on samples to be analyzed, loading 32 ug of total protein per
lane.
2. Transfer proteins to Nitrocellulose according to the instructions provided by the manufacturer of the transfer
apparatus.
3. Rinse membrane with dH2O and then stain the blot using Ponceau S for 1-2 minutes to access the transfer of proteins onto the nitrocellulose membrane. Rinse the blot in water to remove excess stain and mark the lane locations and locations of molecular weight markers using a pencil.
4. Rinse the blot in TBS for approximately 5 minutes.
5. Block the membrane using 5% non-fat dry milk + 1% BSA in TBS, 1 hour at room temperature.
6. Rinse the membrane in dH2O and then wash the membrane in wash buffer [TBS + 0.1% Tween] 3 times for 10 minutes each.
7. Dilute the rabbit anti-ATP13A2 primary antibody (NB110-41486) in blocking buffer and incubate 2 hours at room temperature.
8. Rinse the membrane in dH2O and then wash the membrane in wash buffer [TBS + 0.1% Tween] 3 times for 10 minutes each.
9. Apply the diluted rabbit-IgG HRP-conjugated secondary antibody in blocking buffer (as per manufacturers
instructions) and incubate 1 hour at room temperature.
10. Wash the blot in wash buffer [TBS + 0.1% Tween] 3 times for 10 minutes each (this step can be repeated as required to reduce background).
11. Apply the detection reagent of choice in accordance with the manufacturers instructions (Pierce's ECL).
Note: Tween-20 can be added to the blocking or antibody diultion buffer at a final concentration of 0.05-0.2%, provided it does not interfere with antibody-antigen binding.
IHC-FFPE sections
I. Deparaffinization:
A. Treat slides with Xylene: 3 changes for 5 minutes each. Drain slides for 10 seconds between changes.
B. Treat slides with 100% Reagent Alcohol: 3 changes for 5 minutes each. Drain slides for 10 seconds between changes.
II. Quench Endogenous Peroxidase:
A. Place slides in peroxidase quenching solution: 15-30 minutes.
To Prepare 200 ml of Quenching Solution:
Add 3 ml of 30% Hydrogen Peroxide to 200 ml of Methanol.
Use within 4 hours of preparation
B. Place slides in distilled water: 2 changes for 2 minutes each.
III. Retrieve Epitopes:
A. Preheat Citrate Buffer. Place 200 ml of Citrate Buffer Working Solution into container, cover and place into steamer. Heat to 90-96 degrees Celcius.
B. Place rack of slides into hot Citrate Buffer for 20 minutes. Cover.
C.Carefully remove container with slides from steamer and cool on bench, uncovered, for 20 minutes.
D. Slowly add distilled water to further cool for 5 minutes.
E. Rinse slides with distilled water. 2 changes for 2 minutes each.
IV. Immunostaining Procedure:
A. Remove each slide from rack and circle tissue section with a hydrophobic barrier pen (e.g. Liquid Blocker-Super Pap-Pen).
B. Flood slide with Wash Solution. Do not allow tissue sections to dry for the rest of the procedure.
C. Drain wash solution and apply 4 drops of Blocking Reagent to each slide and incubate for 15 minutes.
D. Drain Blocking Reagent (do not wash off the Blocking Reagent), apply 200 ul of Primary Antibody solution to each slide, and incubate for 1 hour.
E. Wash slides with Wash Solution: 3 changes for 5 minutes each.
F. Drain wash solution, apply 4 drops of Secondary antibody to each slide and incubate for 1 hour.
G. Wash slides with Wash Solution: 3 changes for 5 minutes each.
H. Drain wash solution, apply 4 drops of DAB Substrate to each slide and develop for 5-10 minutes. Check development with microscope.
I. Wash slides with Wash Solution: 3 changes for 5 minutes each.Wash slides with Wash Solution: 3 changes for 5 minutes each
J. Drain wash solution, apply 4 drops of Hematoxylin to each slide and stain for 1-3 minutes. Increase time if darker counterstaining is desired.
K. Wash slides with Wash Solution: 2-3 changes for 2 minutes each.
L. Drain wash solution and apply 4 drops of Bluing Solution to each slide for 1-2 minutes.
M. Rinse slides in distilled water.
N. Soak slides in 70% reagent alcohol: 3 minutes with intermittent agitation.
O. Soak slides in 95% reagent alcohol: 2 changes for 3 minutes each with intermittent agitation.
P. Soak slides in 100% reagent alcohol: 3 changes for 3 minutes each with intermittent agitation. Drain slides for 10 seconds between each change.
Q. Soak slides in Xylene: 3 changes for 3 minutes each with intermittent agitation. Drain slides for 10 seconds between each change.
R. Apply 2-3 drops of non-aqueous mounting media to each slide and mount coverslip.
S. Lay slides on a flat surface to dry prior to viewing under microscope.
NOTES:
-Use treated slides (e.g. HistoBond) to assure adherence of FFPE sections to slide.
-Prior to deparaffinization, heat slides overnight in a 60 degrees Celcius oven.
-All steps in which Xylene is used should be performed in a fume hood.
-For Epitope Retrieval, a microwave or pressure cooker may be substituted for the steamer method. Adjust times as necessary depending on conditions.
-For the initial IHC run with a new primary antibody, test tissues with and without Epitope Retrieval. In some instances, Epitope Retrieval may not be necessary.
-200 ul is the recommended maximum volume to apply to a slide for full coverage. Using more than 200 ul may allow solutions to wick off the slide and create drying artifacts. For small tissue sections less than 200 ul may be used.
-5 minutes of development with DAB Substrate should be sufficient. Do not develop for more than 10 minutes. If 5 minutes of development causes background staining, further dilution of the primary antibody may be necessary.
-Hematoxylin should produce a light nuclear counterstain so as not to obscure the DAB staining. Counterstain for 1-1 1/2 minutes for nuclear antigens. Counterstain for 2-3 minutes for cytoplasmic and membranous antigens. If darker counterstaining is desired increase time (up to 10 minutes).
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Antigen Retrieval Protocol (PIER)
- Antigen Retrieval for Frozen Sections Protocol
- Appropriate Fixation of IHC/ICC Samples
- Cellular Response to Hypoxia Protocols
- Chromogenic IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Chromogenic Immunohistochemistry Staining of Frozen Tissue
- ClariTSA™ Fluorophore Kits
- Detection & Visualization of Antibody Binding
- Fluorescent IHC Staining of Frozen Tissue Protocol
- Graphic Protocol for Heat-induced Epitope Retrieval
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Graphic Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- IHC Sample Preparation (Frozen sections vs Paraffin)
- Immunofluorescent IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Immunohistochemistry (IHC) and Immunocytochemistry (ICC) Protocols
- Immunohistochemistry Frozen Troubleshooting
- Immunohistochemistry Paraffin Troubleshooting
- Preparing Samples for IHC/ICC Experiments
- Preventing Non-Specific Staining (Non-Specific Binding)
- Primary Antibody Selection & Optimization
- Protocol for Heat-Induced Epitope Retrieval (HIER)
- Protocol for Making a 4% Formaldehyde Solution in PBS
- Protocol for VisUCyte™ HRP Polymer Detection Reagent
- Protocol for the Preparation & Fixation of Cells on Coverslips
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections - Graphic
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections - Graphic
- Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- R&D Systems Quality Control Western Blot Protocol
- TUNEL and Active Caspase-3 Detection by IHC/ICC Protocol
- The Importance of IHC/ICC Controls
- Troubleshooting Guide: Immunohistochemistry
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars
FAQs for ATP13A2 Antibody - BSA Free
-
Q: Would you be able to share the protocol used to produce the WB image for NB110-41486 - ATP13A2 antibody?
A:
Please find the specific protocol used for NB110-41486 in Western Blot from this link: Western Blot Protocol
-
Q: Would you be able to share whether or not NB110-41486 is expected to react with rat ATP13A2 (http://www.uniprot.org/uniprot/?query=atp13a2&fil=organism%3A%22Rattus+… (http://www.uniprot.org/uniprot/?query=atp13a2&f
A: According to the information I have available, it looks like there is an 89% homology between the region where the immunogen lies of the human sequence and the corresponding region of the rat sequence. However, the rat sequence is uncharacterized, so we cannot guarantee the accuracy of the homology. It looks like this is promising; however, we have not yet tested this antibody in rat and cannot guarantee its performance.
-
Q: Would you be able to share the protocol used to produce the WB image for NB110-41486 - ATP13A2 antibody?
A:
Please find the specific protocol used for NB110-41486 in Western Blot from this link: Western Blot Protocol
-
Q: Would you be able to share whether or not NB110-41486 is expected to react with rat ATP13A2 (http://www.uniprot.org/uniprot/?query=atp13a2&fil=organism%3A%22Rattus+… (http://www.uniprot.org/uniprot/?query=atp13a2&f
A: According to the information I have available, it looks like there is an 89% homology between the region where the immunogen lies of the human sequence and the corresponding region of the rat sequence. However, the rat sequence is uncharacterized, so we cannot guarantee the accuracy of the homology. It looks like this is promising; however, we have not yet tested this antibody in rat and cannot guarantee its performance.